CME move highlights demand for 'regulatory choice'

The capacity to offer a 'choice' of regulatory regimes is becoming increasingly important as market infrastructure providers attempt to globalise

The decision by the CME Group to establish a European exchange highlights the growing demand among trading firms for "regulatory choice", the company has said.

The CME Group this morning confirmed plans to launch a London-based derivatives exchange, in a move that will see it compete with rivals run by NYSE Euronext and Deutsche Börse. The derivatives giant is applying to the UK Financial Services Authority for a recognised investment exchange license and will initially begin trading foreign exchange futures products in mid-2013, the company said.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump